Detalhe da pesquisa
1.
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522.
Ann Oncol
; 35(5): 429-436, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369015
2.
Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023.
Ann Oncol
; 34(11): 970-986, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683978
3.
ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC).
Ann Oncol
; 34(10): 849-866, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37572987
4.
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer.
Ann Oncol
; 34(8): 645-659, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269905
5.
Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response.
Ann Oncol
; 33(11): 1149-1158, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35961599
6.
The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition.
Ann Oncol
; 32(10): 1236-1244, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34311075
7.
Outcome of breast cancer patients with low hormone receptor positivity: analysis of a 15-year population-based cohort.
Ann Oncol
; 32(11): 1410-1424, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34419555
8.
Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial.
Ann Oncol
; 32(12): 1590-1596, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34520831
9.
Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapyâ.
Ann Oncol
; 32(4): 500-511, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33418062
10.
Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study).
Ann Oncol
; 32(1): 49-57, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33098995
11.
Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo.
Ann Oncol
; 31(9): 1216-1222, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32461104
12.
EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer.
Breast Cancer Res Treat
; 182(1): 137-146, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32436145
13.
Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning.
Semin Cancer Biol
; 52(Pt 2): 151-157, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29990622
14.
Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019.
Ann Oncol
; 30(10): 1541-1557, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31373601
15.
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study.
Ann Oncol
; 30(8): 1279-1288, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31095287
16.
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol
; 35(2): 159-182, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38101773
17.
A GCIG international survey: clinical practice patterns of sentinel lymph node biopsies in cervical cancer.
Arch Gynecol Obstet
; 300(1): 191-199, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31006839
18.
[Update of the German S3 breast cancer guideline : What is new for pathologists?] / Update der S3-Leitlinie Mammakarzinom : Was gibt es Neues für Pathologen?
Pathologe
; 40(2): 185-198, 2019 Mar.
Artigo
em Alemão
| MEDLINE | ID: mdl-30847505
19.
A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer.
Ann Oncol
; 29(1): 162-169, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29077781
20.
Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixto.
Ann Oncol
; 29(12): 2341-2347, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30335131